These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17898798)

  • 21. Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells.
    Sanchez-Perez L; Gough M; Qiao J; Thanarajasingam U; Kottke T; Ahmed A; Thompson JM; Maria Diaz R; Vile RG
    Gene Ther; 2007 Jul; 14(13):998-1009. PubMed ID: 17443216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell transduction and suicide with an enhanced mutant thymidine kinase.
    Qasim W; Thrasher AJ; Buddle J; Kinnon C; Black ME; Gaspar HB
    Gene Ther; 2002 Jun; 9(12):824-7. PubMed ID: 12040465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
    Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
    Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus.
    Raki M; Hakkarainen T; Bauerschmitz GJ; Särkioja M; Desmond RA; Kanerva A; Hemminki A
    Gene Ther; 2007 Oct; 14(19):1380-8. PubMed ID: 17611584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
    Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T
    Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
    Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
    Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound.
    Aoi A; Watanabe Y; Mori S; Takahashi M; Vassaux G; Kodama T
    Ultrasound Med Biol; 2008 Mar; 34(3):425-34. PubMed ID: 18096302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced growth in response to ganciclovir treatment of subcutaneous xenografts expressing HSV-tk in the vascular compartment.
    Mavria G; Porter CD
    Gene Ther; 2001 Jun; 8(12):913-20. PubMed ID: 11426331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
    Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
    Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.
    Kagaya T; Nakamoto Y; Sakai Y; Tsuchiyama T; Yagita H; Mukaida N; Kaneko S
    Cancer Gene Ther; 2006 Apr; 13(4):357-66. PubMed ID: 16224495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J; Chen Y; Li H; Lu Y; Yan Y; Tan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.
    Kawashita Y; Ohtsuru A; Miki F; Kuroda H; Morishita M; Kaneda Y; Hatsushiba K; Kanematsu T; Yamashita S
    Gene Ther; 2005 Nov; 12(22):1633-9. PubMed ID: 16079887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector.
    Iwai M; Harada Y; Tanaka S; Muramatsu A; Mori T; Kashima K; Imanishi J; Mazda O
    Biochem Biophys Res Commun; 2002 Feb; 291(1):48-54. PubMed ID: 11829460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
    Rautsi O; Lehmusvaara S; Ketola A; Määttä AM; Wahlfors J; Pellinen R
    Cancer Gene Ther; 2008 May; 15(5):303-14. PubMed ID: 18309353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase.
    Hattori Y; Maitani Y
    Cancer Gene Ther; 2005 Oct; 12(10):796-809. PubMed ID: 15891776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
    Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
    Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
    Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
    J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
    Maury S; Litvinova E; Boyer O; Benard L; Bruel S; Klatzmann D; Cohen JL
    Gene Ther; 2002 Feb; 9(3):201-7. PubMed ID: 11859423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
    Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
    Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.